BIAsp-30

biphasic insulin aspart protamine 30% / insulin aspart 70% · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BIAsp-30, covering 2015-11-20 to 2018-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes [Phase 3]

See pricing